标题
Vaccine adjuvants as potential cancer immunotherapeutics
作者
关键词
-
出版物
INTERNATIONAL IMMUNOLOGY
Volume 28, Issue 7, Pages 329-338
出版商
Oxford University Press (OUP)
发表日期
2016-03-23
DOI
10.1093/intimm/dxw015
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- A randomized pilot trial testing the safety and immunologic effects of a MAGE-A3 protein plus AS15 immunostimulant administered into muscle or into dermal/subcutaneous sites
- (2015) Craig L. Slingluff et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- TLR9 and STING agonists synergistically induce innate and adaptive type-II IFN
- (2015) Burcu Temizoz et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
- (2015) Robyn Marty-Roix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Autophagy: a druggable process that is deregulated in aging and human disease
- (2015) Guido Kroemer JOURNAL OF CLINICAL INVESTIGATION
- Intrapulmonary Delivery of CpG Microparticles Eliminates Lung Tumors
- (2015) T. Sato et al. MOLECULAR CANCER THERAPEUTICS
- Defined TLR3-specific adjuvant that induces NK and CTL activation without significant cytokine production in vivo
- (2015) Misako Matsumoto et al. Nature Communications
- TLR-3 stimulation improves anti-tumor immunity elicited by dendritic cell exosome-based vaccines in a murine model of melanoma
- (2015) Martina Damo et al. Scientific Reports
- Synergistic Anticancer Effects of Pam3CSK4 and Ara-C on B-Cell Lymphoma Cells
- (2014) S.-K. Lee et al. CLINICAL CANCER RESEARCH
- A Randomized, Multicenter, Placebo-Controlled Clinical Trial of Racotumomab-Alum Vaccine as Switch Maintenance Therapy in Advanced Non-Small Cell Lung Cancer Patients
- (2014) S. Alfonso et al. CLINICAL CANCER RESEARCH
- Toll receptor agonist therapy of skin cancer and cutaneous T-cell lymphoma
- (2014) Auris O. Huen et al. CURRENT OPINION IN ONCOLOGY
- STING-Dependent Cytosolic DNA Sensing Mediates Innate Immune Recognition of Immunogenic Tumors
- (2014) Seng-Ryong Woo et al. IMMUNITY
- Cancer vaccine adjuvants – recent clinical progress and future perspectives
- (2014) Abid H. Banday et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- ISCOMATRIX Adjuvant Induces Efficient Cross-Presentation of Tumor Antigen by Dendritic Cells via Rapid Cytosolic Antigen Delivery and Processing via Tripeptidyl Peptidase II
- (2014) M. Schnurr et al. JOURNAL OF IMMUNOLOGY
- Inflammasome-Dependent and -Independent IL-18 Production Mediates Immunity to the ISCOMATRIX Adjuvant
- (2014) N. S. Wilson et al. JOURNAL OF IMMUNOLOGY
- Structure-based programming of lymph-node targeting in molecular vaccines
- (2014) Haipeng Liu et al. NATURE
- DMXAA Causes Tumor Site-Specific Vascular Disruption in Murine Non-Small Cell Lung Cancer, and like the Endogenous Non-Canonical Cyclic Dinucleotide STING Agonist, 2′3′-cGAMP, Induces M2 Macrophage Repolarization
- (2014) Charlene M. Downey et al. PLoS One
- Nonagonistic Dectin-1 ligand transforms CpG into a multitask nanoparticulate TLR9 agonist
- (2014) K. Kobiyama et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- CpG ODN Nanorings Induce IFN from Plasmacytoid Dendritic Cells and Demonstrate Potent Vaccine Adjuvant Activity
- (2014) B. Gungor et al. Science Translational Medicine
- STING Ligand c-di-GMP Improves Cancer Vaccination against Metastatic Breast Cancer
- (2014) D. Chandra et al. Cancer Immunology Research
- Therapeutic In Situ Autovaccination against Solid Cancers with Intratumoral Poly-ICLC: Case Report, Hypothesis, and Clinical Trial
- (2014) A. M. Salazar et al. Cancer Immunology Research
- Phase II study of everolimus-erlotinib in previously treated patients with advanced non-small-cell lung cancer
- (2013) B. Besse et al. ANNALS OF ONCOLOGY
- Chitin, Chitosan, and Glycated Chitosan Regulate Immune Responses: The Novel Adjuvants for Cancer Vaccine
- (2013) Xiaosong Li et al. Clinical & Developmental Immunology
- The nanoparticulation by octaarginine-modified liposome improves α-galactosylceramide-mediated antitumor therapy via systemic administration
- (2013) Takashi Nakamura et al. JOURNAL OF CONTROLLED RELEASE
- Mouse, but not Human STING, Binds and Signals in Response to the Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid
- (2013) J. Conlon et al. JOURNAL OF IMMUNOLOGY
- TLR agonists: our best frenemy in cancer immunotherapy
- (2013) Sabina Kaczanowska et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Pediatric Phase II Trials of Poly-ICLC in the Management of Newly Diagnosed and Recurrent Brain Tumors
- (2013) Lisa L.R. Hartman et al. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Persistent antigen at vaccination sites induces tumor-specific CD8+ T cell sequestration, dysfunction and deletion
- (2013) Yared Hailemichael et al. NATURE MEDICINE
- The Chemotherapeutic Agent DMXAA as a Unique IRF3-Dependent Type-2 Vaccine Adjuvant
- (2013) Choon Kit Tang et al. PLoS One
- Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy
- (2013) Adam Yuh Lin et al. PLoS One
- The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
- (2013) M. Vono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
- (2013) A. de Titta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pivotal Roles of cGAS-cGAMP Signaling in Antiviral Defense and Immune Adjuvant Effects
- (2013) X.-D. Li et al. SCIENCE
- MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice
- (2012) Ming Yang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Quorum-Sensing in CD4+ T Cell Homeostasis: A Hypothesis and a Model
- (2012) Afonso R. M. Almeida et al. Frontiers in Immunology
- Trial watch
- (2012) Erika Vacchelli et al. OncoImmunology
- PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
- (2011) M. A. Cheever et al. CLINICAL CANCER RESEARCH
- Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
- (2011) Nathalie Garçon et al. Expert Review of Vaccines
- TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
- (2011) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- STING is a direct innate immune sensor of cyclic di-GMP
- (2011) Dara L. Burdette et al. NATURE
- DNA released from dying host cells mediates aluminum adjuvant activity
- (2011) Thomas Marichal et al. NATURE MEDICINE
- Innate immunity and adjuvants
- (2011) S. Akira PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine for use in the prevention of visceral leishmaniasis
- (2011) Jaya Chakravarty et al. VACCINE
- Therapeutic Targeting of TLR9 Inhibits Cell Growth and Induces Apoptosis in Neuroblastoma
- (2010) C. Brignole et al. CANCER RESEARCH
- Pattern Recognition Receptors and Inflammation
- (2010) Osamu Takeuchi et al. CELL
- TLR signalling regulated antigen presentation in dendritic cells
- (2010) Colin Watts et al. CURRENT OPINION IN IMMUNOLOGY
- An ISCOM vaccine combined with a TLR9 agonist breaks immune evasion mediated by regulatory T cells in an orthotopic model of pancreatic carcinoma
- (2010) Collin Jacobs et al. INTERNATIONAL JOURNAL OF CANCER
- A novel liposomal vaccine improves humoral immunity and prevents tumor pulmonary metastasis in mice
- (2010) Zhenghua Zhong et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Regulation of Adaptive Immunity by the Innate Immune System
- (2010) A. Iwasaki et al. SCIENCE
- A virosomal formulated Her-2/neu multi-peptide vaccine induces Her-2/neu-specific immune responses in patients with metastatic breast cancer: a phase I study
- (2009) Ursula Wiedermann et al. BREAST CANCER RESEARCH AND TREATMENT
- Anticancer immunochemotherapy using adjuvants with direct cytotoxic effects
- (2009) Laurence Zitvogel et al. JOURNAL OF CLINICAL INVESTIGATION
- A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP
- (2009) Sarah M. McWhirter et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The effects of β-glucan on human immune and cancer cells
- (2009) Godfrey Chan et al. Journal of Hematology & Oncology
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women
- (2009) J Paavonen et al. LANCET
- Ampligen: A potential toll-like 3 receptor adjuvant for immunotherapy of cancer
- (2009) B. Jasani et al. VACCINE
- Synthetic Double-Stranded RNAs Are Adjuvants for the Induction of T Helper 1 and Humoral Immune Responses to Human Papillomavirus in Rhesus Macaques
- (2009) Christiane Stahl-Hennig et al. PLoS Pathogens
- Cytoplasmic recognition of RNA☆
- (2008) M YONEYAMA et al. ADVANCED DRUG DELIVERY REVIEWS
- Engagement of Toll-like receptor-2 on cytotoxic T-lymphocytes occurs in vivo and augments antitumor activity
- (2008) Nicole Asprodites et al. FASEB JOURNAL
- Multiple roles for CD4+T cells in anti-tumor immune responses
- (2008) Richard Kennedy et al. IMMUNOLOGICAL REVIEWS
- Phase II Randomized Controlled Trial of an Epidermal Growth Factor Vaccine in Advanced Non–Small-Cell Lung Cancer
- (2008) Elia Neninger Vinageras et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial of a Toll-Like Receptor 9 Agonist Oligodeoxynucleotide, PF-3512676, in Combination With First-Line Taxane Plus Platinum Chemotherapy for Advanced-Stage Non–Small-Cell Lung Cancer
- (2008) Christian Manegold et al. JOURNAL OF CLINICAL ONCOLOGY
- STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling
- (2008) Hiroki Ishikawa et al. NATURE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started